Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,088 | -1,459 | -532 | -857 | -684 |
| Depreciation Amortization | 8 | 5 | 2 | 7 | 6 |
| Accounts receivable | 7 | 9 | -7 | -16 | -15 |
| Other Working Capital | 537 | 380 | 309 | 250 | 234 |
| Other Operating Activity | 676 | 584 | 154 | 304 | 195 |
| Operating Cash Flow | $-861 | $-481 | $-73 | $-311 | $-265 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | N/A | -1 | -1 |
| Purchase Sale Intangibles | -2 | -41 | -40 | N/A | N/A |
| Other Investing Activity | -2 | -41 | -40 | 0 | 0 |
| Investing Cash Flow | $-4 | $-43 | $-40 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -71 | N/A | 41 | 235 | 175 |
| Debt Repayment | N/A | N/A | N/A | -54 | N/A |
| Common Stock Issued | 893 | 534 | 35 | 175 | 144 |
| Other Financing Activity | 95 | -49 | 0 | 0 | -53 |
| Financing Cash Flow | $917 | $485 | $76 | $356 | $265 |
| Exchange Rate Effect | -20 | -1 | -1 | -1 | -1 |
| Beginning Cash Position | 43 | 43 | 41 | 1 | 1 |
| End Cash Position | 75 | 3 | 4 | 43 | 0 |
| Net Cash Flow | $32 | $-40 | $-37 | $42 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -861 | -481 | -73 | -311 | -265 |
| Capital Expenditure | -2 | -2 | N/A | -1 | -1 |
| Free Cash Flow | -863 | -483 | -73 | -313 | -265 |